Borteplus – Bortezomib 2mg Injection
Bortezomib (Borteplus) Injection – Treatment for Multiple Myeloma
Multiple myeloma and mantle-cell lymphoma are treated by Bortezomib or Borteplus. Its effectiveness is demonstrated by the fact that it stops or slows the proliferation of cancer cells. Borteplus an injection is administered by a trained medical expert. Your doctor will determine the appropriate dose and frequency of administration. This can vary depending on the reason you’re being treated and may alter over time. You should follow your doctor’s instructions in the letter. It can have potentially dangerous negative effects if taken incorrectly or in excess. You may not see or feel the advantages for several weeks or months, but do not stop taking it until your doctor advises you to. If you have any liver, kidney, heart, or blood problems, talk to your doctor before using Borteplus Injection. If you have symptoms such as memory loss or difficulty thinking, you should see a doctor. Many other drugs can interact with or be impacted by this one, so tell your doctor about all of your prescriptions. This medication should not be used during pregnancy or nursing. It is critical for both males and females to utilize effective contraception throughout therapy to avoid conception.
Bortezomib is manufactured by Alkem Laboratories Limited, which is an Indian multinational pharmaceutical firm based in Mumbai, Maharashtra, India that makes and sells pharmaceutical generics, formulations, and nutraceuticals in India and across the world.
USES OF BORTEZOMIB (BORTEPLUS) 2MG INJECTION
- Multiple myeloma
- Mantle-cell lymphoma
HOW BORTEZOMIB (BORTEPLUS) 2MG INJECTION WORKS
Bortezomib or Borteplus Injection is a cancer-fighting drug. It works by preventing or decreasing protein degradation in cells. As a result, the number of proteins in cancer cells increases, leading to their demise.
Fedelty Health Care is a certified Bortezomib Bulk Pharma Exporter, Cargo Bulk Supplier, and pharmaceutical wholesaler in India.
DIRECTIONS FOR USE
This drug will be given to you by your doctor or nurse. Please do not self-medicate.
SIDE EFFECTS OF BORTEZOMIB (BORTEPLUS) 2MG INJECTION
- Low blood platelets
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Loss of appetite
- Anemia (low number of red blood cells)
- Decreased appetite
- Decreased white blood cell count (neutrophils)
WARNING & PRECAUTIONS
Bortezomib Injections may have negative effects that impair your driving skills. Borteplus Tiredness, dizziness, fainting, or blurred vision may occur after injection, affecting your ability to drive.
In individuals with severe renal disease, Bortezomib Injection should be taken with care. Bortezomib Injection dosage may need to be adjusted. Please seek medical advice.
On the usage of Borteplus Injection in these individuals, there is limited information.
In individuals with liver problems, Bortezomib Injection should be taken with care. Bortezomib Injection dosage may need to be adjusted. Please seek medical advice.
Bortezomib is a supplement that contains the active ingredient Borteplus. Injections should not be used during pregnancy since there is clear evidence that they pose a risk to the unborn child. However, if the advantages outweigh the hazards, the doctor may prescribe it in life-threatening conditions. Please get medical advice from your physician.
Bortezomib Using injections during nursing is risky. The medicine may induce toxicity in the newborn, according to the data.
Fedelty Health Care is a Bortezomib bulk pharma exporter (Borteplus Exporter) and pharmaceutical third-party manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.